Samrat Pharmachem Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €28.18M +1.5% €701.23K +228.9% 2.5% +0.017 pp -€969.70K -197.6% -3.4% -0.070 pp
    €27.76M -9.4% €213.22K -87.0% 0.8% -0.046 pp €993.72K -224.8% 3.6% +0.062 pp
    €30.63M +40.1% €1.64M -3.2% 5.4% -0.024 pp -€796.36K -143.1% -2.6% -0.11 pp
    €21.86M +23.9% €1.69M +222.2% 7.7% +0.048 pp €1.85M +149.1% 8.5% +0.043 pp
    €17.65M +30.3% €525.83K +25.9% 3.0% -0.0010 pp €742.05K +1,355.7% 4.2% +0.038 pp
    €13.55M +23.7% €417.73K +175.9% 3.1% +0.017 pp €50.97K -80.6% 0.4% -0.020 pp
    €10.95M +20.2% €151.40K -52.3% 1.4% -0.021 pp €262.92K +746.7% 2.4% +0.021 pp
    €9.11M +30.1% €317.17K +83.4% 3.5% +0.010 pp €31.05K -112.1% 0.3% +0.040 pp
    €7.01M +14.9% €172.98K +482.3% 2.5% +0.020 pp -€256.53K -1,749.4% -3.7% -0.039 pp
    €6.10M +30.7% €29.71K -4.6% 0.5% -0.0018 pp €15.55K -141.2% 0.3% +0.011 pp
    €4.67M -27.0% €31.16K +30.7% 0.7% +0.0029 pp -€37.77K -108.7% -0.8% -0.076 pp
    €6.39M -8.1% €23.84K -39.6% 0.4% -0.0019 pp €434.22K -600.1% 6.8% +0.080 pp
    €6.95M +1.4% €39.47K -89.4% 0.6% -0.049 pp -€86.83K -111.6% -1.2% -0.12 pp
    €6.86M +60.1% €372.43K +181.4% 5.4% +0.023 pp €748.18K +11,475.2% 10.9% +0.11 pp
    €4.28M -9.5% €132.33K +18.9% 3.1% +0.0074 pp €6.46K -94.8% 0.2% -0.025 pp
    €4.73M +23.1% €111.32K -1,195.4% 2.4% +0.026 pp €124.89K +60.0% 2.6% +0.0061 pp
    €3.84M -€10.16K -0.3% €78.04K 2.0%

    Notifications